http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009108643-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2007-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009108643-A |
| titleOfInvention | MEDICINES STRENGTHENING THE REPAIR OF THE SPINAL NERVES, CONTAINING AN ACTIVE GRELIN INGREDIENT OR ITS DERIVATIVES OR SUBSTANCES THAT ARE ACTING ON GHS-R1A |
| abstract | 1. An agent for the treatment of damage to neurons of the spinal cord, containing as an active ingredient a substance that acts on a receptor that enhances the secretion of growth hormones, or its pharmaceutically acceptable salt. ! 2. The treatment agent according to claim 1, wherein the substance is a peptide selected from the group consisting of:! (1) a peptide whose amino acid sequence corresponds to any of SEQ ID NO: 1 to SEQ ID NO: 21, provided that the third amino acid residue from the N-terminus is a modified amino acid residue having a fatty acid embedded in the side chain of this amino acid residue; ! (2) a peptide whose amino acid sequence matches any one of SEQ ID NO: 1 to SEQ ID NO: 21, provided that one or more amino acids in the sequence of 5 to 28 amino acids from the N-terminus are deleted, substituted and / or inserted and that the third amino acid residue from the N-terminus is a modified amino acid residue having a fatty acid embedded in the side chain of this amino acid residue, the peptide having a proliferative effect on the progenitor cell of the spinal cord neurons; and! (3) a peptide having a sequence of up to at least 4 amino acids from the N-terminus of the amino acid sequence that matches any of SEQ ID NO: 1 to SEQ ID NO: 21, wherein the third amino acid residue from the N-terminus is modified an amino acid residue having a fatty acid embedded in the side chain of this amino acid residue, the peptide having a proliferative effect on the progenitor cell of the spinal cord neurons,! � |
| priorityDate | 2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396493 |
Total number of triples: 18.